title: Oritavancin (Orbactiv) for skin and skin structure infections.
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000378:metabolism; D002986:Clinical Trials as Topic / Q000379:methods; D006020:Glycopeptides / Q000008:administration & dosage* / Q000378:metabolism; D006801:Humans; D007275:Injections, Intravenous; D000077427:Lipoglycopeptides; D017192:Skin Diseases, Bacterial / Q000188:drug therapy* / Q000378:metabolism; D014640:Vancomycin / Q000031:analogs & derivatives
chemical_list: D000900:Anti-Bacterial Agents; D006020:Glycopeptides; D000077427:Lipoglycopeptides; C100708:oritavancin; D014640:Vancomycin